Benign meningiomas: primary treatment selection affects survival.
about
The biology of radiosurgery and its clinical applications for brain tumors.Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewPatterns of failure after treatment of atypical meningioma with gamma knife radiosurgeryFractionated stereotactic conformal radiotherapy for large benign skull base meningiomasRadiotherapy and radiosurgery for benign skull base meningiomas.Management of benign skull base meningiomas: a review.CyberKnife radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters.Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.Bone involvement predicts poor outcome in atypical meningioma.Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.Fractionated stereotactic radiotherapy: a short review.Complications after gamma knife radiosurgery for benign meningiomas.Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Clinical article.Impaired survival and long-term neurological problems in benign meningioma.Primary radiotherapy for optic nerve sheath meningioma.Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features.Long-term follow-up result of hydroxyurea chemotherapy for recurrent meningiomasPatterns of Care and Outcomes of Adjuvant Radiotherapy for Meningiomas: A Surveillance, Epidemiology, and End Results and Medicare Linked Analysis.Children's Cancer and Leukaemia Group (CCLG): guidelines for the management of intracranial meningioma in children and young people.Five fraction image-guided radiosurgery for primary and recurrent meningiomas.Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?Intracranial meningiomas of atypical (WHO grade II) histology.Fractionated radiotherapy for intracranial meningiomas.Opportunities for clinical research in meningioma.Contemporary surgical outcome for skull base meningiomas.Stereotactic radiosurgery for benign meningiomas.Stereotactic radiosurgery for intracranial meningiomas: current concepts and future perspectives.Lessons learned from reirradiation of recurrent skull base meningioma: A case report and review of the literature.Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment ActLong term outcome analysis of role of radiotherapy in Grade I meningiomas: A single centre experience from North IndiaPrognostic Factors of Atypical Meningioma: Overall Survival Rate and Progression Free Survival Rate.Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients.Three-dimensional conformal radiation therapy alone or in combination with surgery for treatment of canine intracranial meningiomas.Clinical research in stereotactic radiosurgery: lessons learned from over 10,000 cases.Surgery for convexity meningiomas.[Relevance of Simpson's grades in the resection of grade I meningiomas].Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review.Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.Parameters influencing local control of meningiomas treated with radiosurgery.
P2860
Q26829154-835842C5-9349-4180-BF55-200254E60838Q30356126-7F65912E-948B-4094-A9E6-D3265C590D50Q30448386-D96B813F-9709-43D0-9EAB-27153585861EQ30475500-329D563F-7D2F-4AC4-8F7D-B8A91380EE92Q30485812-F2E2ACD1-A39E-453C-85E4-8E29A0AFEA5AQ30499508-62A55CC8-3F65-42D8-8690-9E288D5744C4Q30501050-CD4D0677-2A77-46FD-A8D8-0C8133C37916Q31019173-7AD0D68D-6E53-41A7-B366-F772A1842499Q33754770-034F06DD-A2D5-4341-AE00-23E5ECC73DCAQ33760861-5A975362-162A-4038-8DCD-5011728DBDBAQ35079977-993B8E6B-FEA1-429D-985C-69064D2E6846Q35471258-98855711-5CFC-4CC7-B1D2-1069B054E41FQ35668363-F306F7BB-5AAF-43E3-B67C-3C048521DE44Q35914505-705A955D-C08B-4029-BE62-3E15C473FEC4Q35980041-053C7131-CD47-40A7-BADD-48C265647C3EQ36230010-A8F0B53F-D30D-49C0-A0D4-5FED50E2ADF8Q36549467-E05DC091-FB95-4C25-A9F8-A1DC90738F03Q36900794-B3C8D3C3-F757-4C87-90F8-55DB49B22089Q37068833-80B00D9F-8735-44AA-9111-FD6740804222Q37105250-BA9AA378-78AF-41C0-B51A-74E4BCE60DC7Q37273561-B86647B4-31C3-43CC-BE19-1CF4E517043EQ37782558-6049F1E5-5453-4915-B464-D672536748A5Q37784452-87743E61-12C8-43AE-BC37-BBF16B7ECBC9Q37787859-1CD6D834-E322-4979-B48B-BC9D82499ACFQ37879957-52758F57-D46F-4B08-8A3C-E52F277FA105Q37946752-71FC0701-5DCC-429D-9D66-A9431E971C0FQ38323132-47C4E117-85F5-4D4C-A02C-1E5C7B96F5FEQ39456183-96C200ED-AA26-4F4A-8D31-4515CC5D01AEQ41074722-B32E4054-3D38-4995-9EA1-DB14252F9DF2Q41838969-0CDCD1D5-B348-4818-9D46-1776F9EFD2C1Q44148386-B6B8EFD3-E425-491D-AA79-B14956D169B7Q45083238-8FB7C4E0-7260-40B5-9C03-36BC8C66B57CQ45211283-9326F3A4-B710-433C-BD48-638BC327F16FQ45782311-1BC66E31-4E7D-47F0-AADC-3DCAADED8FF6Q45782445-BDA09AB1-EAA8-41E1-9B51-9E4E3DBF54FCQ45936340-1E0438AD-93D4-45DD-B6B6-29C2C17050B2Q46075799-6B64A114-EF8B-4242-9BFA-44D5A346EA88Q46080652-6811A3AF-CFDE-45FD-AE95-3423BD61BB93Q46429525-FC186FC1-655D-4118-B06F-CCA6B2360E4AQ46791478-6583FBA6-C129-4189-9349-FFB9009F36C4
P2860
Benign meningiomas: primary treatment selection affects survival.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Benign meningiomas: primary treatment selection affects survival.
@en
Benign meningiomas: primary treatment selection affects survival.
@nl
type
label
Benign meningiomas: primary treatment selection affects survival.
@en
Benign meningiomas: primary treatment selection affects survival.
@nl
prefLabel
Benign meningiomas: primary treatment selection affects survival.
@en
Benign meningiomas: primary treatment selection affects survival.
@nl
P2093
P1476
Benign meningiomas: primary treatment selection affects survival
@en
P2093
A L Rhoton
K S Condra
R B Marcus
W A Friedman
W M Mendenhall
P304
P356
10.1016/S0360-3016(97)00317-9
P407
P577
1997-09-01T00:00:00Z